2Suppliers
3Customers
1Debt Items
20Related Chains

Oatly Group AB Suppliers

TickerNameConfidenceEvidence
JNJ Johnson & Johnson 72% al requirements in each such market. 56 Competition While we operate in a highly competitive market, we believe that our position as category creator, our commercial performance, brand equity, scienc…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from OTLY graph: al requirements in each such market. 56 Competition While we operate in a highly competitive market, we believe that o…

Oatly Group AB Customers

TickerNameConfidenceEvidence
ONE-CUSTOMER-IN-THE-FOODSERVICE-CHANNEL ONE-CUSTOMER-IN-THE-FOODSERVICE-CHANNEL 90% In the year ended December 31, 2025, one customer in the foodservice channel accounted for approximately 6% of our total revenue.
JNJ Johnson & Johnson 72% mity to our consumers as well as our co-manufacturers, where possible. This allows us to reduce our transportation costs, which can help us to lower our environmental impact and can drive production …
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from OTLY graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from OTLY graph: Reciprocal relationship from JNJ grap…

Oatly Group AB Debt Obligations

InstrumentDescriptionConfidenceEvidence
OTLY-DEBT Debt stack $547.0M 90% Market cache reports total debt of $547.0M.

Oatly Group AB Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Oatly Group AB.

Oatly Group AB Ownership

HolderNameConfidenceEvidence
OTLY-OWNER-BLACKSTONE-INC Blackstone Inc. 90% 13F overlay lists Blackstone Inc. as top holder; 65 tracked holders.

Oatly Group AB Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ADGM Adagio Medical Holdings, Inc. 100.00 2
ATON AlphaTON Capital Corp 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
TRIB Trinity Biotech plc 100.00 2
ABBV AbbVie Inc. 100.00 2
AURA Aura Biosciences, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
ACIU AC Immune SA 100.00 2
SNNUF Smith & Nephew plc 100.00 2
AORT Artivion, Inc. 100.00 2
ALC Alcon Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2